PHARM FINAL please god Flashcards
Antitussives (respiratory drug)
Medications:
o Benzonatate
o Codeine (generic)
o Hydrocodone (generic)
o Dextromethorphan (prototype)
Actions:
o Act directly on the medullary cough center of the
brain to depress the cough reflex
Indications:
o Control nonproductive cough
Adverse Effects:
o Drying effect on the mucous membranes
o CNS adverse effects and GI upset
Topical Nasal Decongestants (respiratory drug)
Medications:
o “Zoline” (prototype)
o Phenylephrine
Actions:
o Affects the sympathetic nervous system.
o Decrease the overproduction of secretions by causing local vasoconstriction & decrease the blood flow to the upper respiratory tract.
Indications:
o Relieve the discomfort of nasal congestion that
accompanies the common cold, sinusitis, and allergic rhinitis.
Adverse Effects:
o Local stinging and burning
o Rebound congestion
o Sympathomimetic effects
Oral decongestants (respiratory medication)
Medication:
o Pseudoephedrine (prototype)
Actions:
o Decrease nasal congestion by vasoconstriction related to the common cold, sinusitis, and allergic rhinitis by shrinking the mucous membrane
indications:
o Promotion of drainage in the sinuses and improving air flow
Adverse Effects:
o Rebound congestion
o Sympathetic effects
Topical Nasal Steroid Decongestants (Respiratory Medication)
Medications:
o Beclomethasone
o Budesonide
o Flunisolide (prototype)
o Fluticasone (generic)
o Triamcinolone (generic)
actions:
o Relieves inflammation]
indications:
o Seasonal allergic rhinitis
o Inflammation after the removal of nasal polyps
Adverse effects:
o Local burning, irritation, stinging, dryness of the
mucosa, and headache
o Suppression of healing can occur in a patient who
has had nasal surgery or trauma
Antihistamines (respiratory medication)
Medications:
“amines” (prototype)
Actions:
o Block the release or action of histamine that increases secretions and narrows airways
o decreases allergic responses
Indications:
o Seasonal and perennial allergic rhinitis, allergic conjunctivitis, uncomplicated urticaria, and angioedema
adverse effects:
o Drowsiness and sedation
o Anticholinergic effects
Expectorants (respiratory medication)
Medication:
o Guaifenesin
Actions:
o increase productive cough to clear the airways. They liquefy lower respiratory tract secretions, reducing the viscosity of these secretions and making it easier for the patient to cough them up.
Indications:
o Symptomatic relief of respiratory conditions characterized by a dry, non-productive cough
Adverse effects:
o GI symptoms
o Headache
o Dizziness
o Mild rash
o Prolonged use may result in masking a serious
underlying disorder
Mucolytics (respiratory medication)
Medications:
o Acetylcysteine (prototype)
o Dornase alfa
Actions:
o Work to break down mucous in order to aid the high-risk respiratory patient in coughing up thick, tenacious secretions.
Indications:
o Patients who have difficulty coughing up secretions
o Patients who develop atelectasis
o Patients undergoing diagnostic bronchoscopy
o Postoperative patients
o Patients with tracheostomies
Adverse effects:
o GI upset
o Stomatitis and/or rhinorrhea
o Bronchospasm
o Rash
Xanthines (respiratory medication)
Medications:
o Caffeine
o Theophylline (prototype)
Actions:
o Direct effect on the smooth muscles of the respiratory tract, both in the bronchi and in the blood vessels
Indications:
o Symptomatic relief or prevention of bronchial asthma and for reversal of bronchospasm associated with COPD
Adverse Effects:
o Related to theophylline levels in the blood
o GI upset, nausea, irritability, and tachycardia to seizure, brain damage, and even death
Sympathomimetics (respiratory medication)
medication:
o Albuterol
o Arformoterol
o Ephedrine (generic)
o Epinephrine (prototype)
o Formoterol
o Indacaterol
o Isoproterenol
o Levalbuterol
o Metaproterenol (generic)
o Olodaterol
o Salmeterol
o Terbutaline (generic)
actions:
o Mimic effects of the sympathetic nervous system: dilation of bronchi with increased rate and depth of respiration
indications:
o Acute asthma attack
o Bronchospasm in acute or chronic asthma
o Prevention of exercise-induced asthma
Adverse effects:
o Sympathomimetic stimulation
o CNS stimulation
o GI upset, cardiac arrhythmias, hypertension,
bronchospasm, sweating, pallor, and flushing
Anticholinergics (respiratory medication)
Medication:
“ium” (prototype)
Actions:
o blocks ach
o Patients who cannot tolerate the sympathetic effects of the sympathomimetic might respond to the anticholinergic drugs
Indications:
o Maintenance treatment of bronchospasm associated with COPD
Adverse effects:
o Dizziness, headache, fatigue, nervousness, dry
mouth, sore throat, palpitations, and urinary
retention
Inhaled steroids (respiratory medication)
medication:
o Beclomethasone
o Budesonide (prototype)
o Ciclesonide
o Fluticasone
o Triamcinolone (generic)
actions:
o Decrease the inflammatory response in the airway
indications:
o Prevention and treatment of asthma
o Treat chronic steroid-dependent bronchial asthma
Adverse effects:
o Sore throat
o Hoarseness
o Coughing
o Dry mouth
o Pharyngeal and laryngeal fungal infections
Leukotriene Receptor Antagonists (respiratory medication)
Medication:
“Kast” (prototype) and Zileuton
Action:
o act more specifically at the site of the problem
associated with asthma
o Selectively and competitively block or antagonize receptors for the production of leukotrienes
indication:
o Prophylaxis and chronic treatment of bronchial asthma in adults and in patients younger than 12 years of age
Adverse effects:
o Headache, dizziness, myalgia, nausea, diarrhea and abdominal pain, elevated liver enzyme
concentrations, vomiting, and generalized pain
Lung surfactants (respiratory medication)
Medications:
“tant” (prototype)
actions:
o Naturally occurring compounds or lipoproteins containing lipids and apoproteins that reduce the surface tension within the alveoli, allowing expansion of the alveoli for gas exchange
indications:
o Rescue treatment of infants who have developed
RDS
adverse effects:
o Patent ductus arteriosus
o Hypotension
o Intraventricular hemorrhage
o Pneumothorax
o Pulmonary air leak
o Hyperbilrubinemia
o Sepsis
Mast cell stabilizers (respiratory medication)
Medication:
Cromolyn
actions:
o Works at the cellular level to inhibit the release of
histamine and inhibits the release of SRSA
indications: Treatment of chronic bronchial asthma
Histamine-2 (H 2 ) Antagonists (GI medication)
Medication:
“Tidine” (prototype)
Actions:
o Selectively block histamine-2 receptor sites
o This blocking leads to a reduction in gastric acid secretion and a reduction in overall pepsin production
indication:
o Short-term treatment of active duodenal ulcer or benign gastric ulcer
o Treatment of pathological hypersecretory conditions such as Zollinger–Ellison syndrome
o Prophylaxis of stress-induced ulcers and acute upper GI bleeding in critical patients
adverse effects:
o GI effects
o CNS effects
o Cardiac arrhythmias and hypotension
Antacids (Gi medications)
Medications:
o Sodium bicarbonate (prototype)
o Calcium carbonate
o Magnesium salts
o Aluminum salts
actions:
o Neutralize stomach acid by direct chemical reaction
indications:
o Symptomatic relief of upset stomach associated with
hyperacidity, as well as hyperactivity
adverse effects:
o Rebound acidity
o Alkalosis
o Hypercalcemia
o Constipation or diarrhea
o Hypophosphatemia
Proton Pump Inhibitors (GI medication)
Medication:
“prazole” (prototype)
Actions:
o Act at specific secretory surface receptors to prevent the final step of acid production and thereby decrease the level of acid in the stomach
Indications:
o Short-term treatment of active duodenal ulcers, GERD, erosive esophagitis, and benign active gastric disease
o Long-term treatment of pathological hypersecretory conditions
adverse effects:
o CNS effects: Dizziness, headache, asthenia, vertigo, insomnia, apathy
o GI Effects: Diarrhea, abdominal pain, and tongue atrophy
o Upper respiratory tract symptoms: Cough, stuff nose, hoarseness, and epistaxis
o Other: Rash, alopecia, pruritis, dry skin, back pain, and fever
